Who owns BioCryst Pharmaceuticals?

Key details on BioCryst Pharmaceuticals (Ticker: BCRX)

Who owns BioCryst Pharmaceuticals?

Is BCRX a good stock to own? Find out who bought BioCryst Pharmaceuticals, who sold BioCryst Pharmaceuticals (BCRX) stock, and who holds a large position in BioCryst Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 10.85M $97.96M March 31, 2015
Baker Bros. Advisors 10.48M $94.62M March 31, 2015
Wellington Management Company 7.02M $63.39M March 31, 2015
RA Capital Management 6.93M $62.55M March 31, 2015
STATE STREET CORPORATION 3.34M $30.17M March 31, 2015
BlackRock Fund Advisors 2.86M $25.83M March 31, 2015
Vanguard 2.46M $22.22M March 31, 2015
Millennium Management 2.43M $21.95M March 31, 2015
RTW INVESTMENTS 2.26M $20.42M March 31, 2015
BlackRock Institutional Trust Company, N.A. 1.91M $17.28M March 31, 2015
VHCP Management 1.74M $15.75M March 31, 2015
D. E. Shaw & Co 1.72M $15.57M March 31, 2015
T. Rowe Price Associates 1.58M $16.75M March 31, 2014
Jennison Associates 1.32M $19.67M June 30, 2015
QVT Financial 1.25M $15.15M Dec. 31, 2014
Technical Financial Services 1.21M $8.84M Sept. 30, 2013
TPG Group Holdings 1.16M $12.30M March 31, 2014
TPG Capital 1.16M $3.21M Sept. 30, 2011
GOLDMAN SACHS 1.03M $9.32M March 31, 2015
Deerfield Management Company 907920 $9.61M March 31, 2014
NORTHERN TRUST 828938 $7.49M March 31, 2015
Driehaus Capital Management 702175 $2.98M Sept. 30, 2012
Cormorant Asset Management 680000 $6.14M March 31, 2015
SUSQUEHANNA INTERNATIONAL 626000 $6.12M Sept. 30, 2014
Connor, Clark & Lunn Investment Management 528098 $6.17M March 31, 2014
MORGAN STANLEY 525306 $5.56M March 31, 2014
Barclays 516100 $2.49M March 31, 2012

Who sold BioCryst Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
BAM Capital Dec. 31, 2010 861485 $4.45M